Luo Q et al. reported serum ORM1 has been shown to be upregulated in the serum of breast cancer patients, ORM1 expression is associated with proinflammatory factors such as interleukin (IL)-1β, IL-8, and tumor necrosis factor-α 32,33. This evidence concerns the gene IL1B and breast carcinoma.